Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TEPROTUMUMAB Cause Therapy partial responder? 12 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Therapy partial responder have been filed in association with TEPROTUMUMAB (TEPEZZA). This represents 8.0% of all adverse event reports for TEPROTUMUMAB.

12
Reports of Therapy partial responder with TEPROTUMUMAB
8.0%
of all TEPROTUMUMAB reports
0
Deaths
0
Hospitalizations

How Dangerous Is Therapy partial responder From TEPROTUMUMAB?

Of the 12 reports.

Is Therapy partial responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TEPROTUMUMAB. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does TEPROTUMUMAB Cause?

Deafness (21) Endocrine ophthalmopathy (19) Deafness bilateral (16) Hyperglycaemia (15) Muscle spasms (14) Deafness neurosensory (12) Tinnitus (11) Diarrhoea (10) Drug ineffective (10) Alopecia (9)

What Other Drugs Cause Therapy partial responder?

CYCLOPHOSPHAMIDE (1,397) RITUXIMAB (1,219) DEXAMETHASONE (1,199) PREDNISONE (1,176) PEMBROLIZUMAB (1,125) CARBOPLATIN (1,096) DOXORUBICIN (834) METHOTREXATE (775) VINCRISTINE (707) ETOPOSIDE (670)

Which TEPROTUMUMAB Alternatives Have Lower Therapy partial responder Risk?

TEPROTUMUMAB vs TEPROTUMUMAB-TRBW TEPROTUMUMAB vs TERAZOSIN TEPROTUMUMAB vs TERAZOSIN\TERAZOSIN TEPROTUMUMAB vs TERBINAFINE TEPROTUMUMAB vs TERBINAFINE\TERBINAFINE

Related Pages

TEPROTUMUMAB Full Profile All Therapy partial responder Reports All Drugs Causing Therapy partial responder TEPROTUMUMAB Demographics